Core Viewpoint - The company reported a solid financial performance with significant growth in revenue and net profit, indicating a stable operational status and strong debt repayment capability [1]. Financial Performance - As of September 30, 2025, the company achieved an operating income of 2.443 billion yuan, representing a year-on-year increase of 10.93% [1]. - The net profit attributable to shareholders reached 273 million yuan, showing a substantial year-on-year growth of 61.89% [1]. - The asset-liability ratio stood at 40.20%, reflecting a reasonable level within the industry and indicating strong debt repayment ability [1]. Business Operations - The company has two main business segments: prestressed materials and concrete products for rail transit, both of which are experiencing steady growth [1]. - Future plans may include upgrades, renovations, and capacity expansions based on operational development needs [1]. Capital Market Strategy - The company is focused on various financing tools in the capital market and will carefully evaluate options such as targeted placements and convertible bonds based on project progress, market conditions, and funding needs [1]. - Any financing plans that meet disclosure standards will be announced in a timely manner according to regulations [1].

Core Viewpoint - The company, Yinlong Co., has established a strong competitive edge in the prestressed materials sector, developing a comprehensive core technology system that spans the entire industry chain from raw material processing to intelligent production of concrete products [1] Group 1: Competitive Advantage - The company has built a core technology system that covers the entire industry chain, from upstream rebar smelting process control to midstream precision processing of prestressed products and downstream intelligent production of concrete products [1] - The company has established itself as a technical benchmark in the industry by leading and participating in the formulation and revision of dozens of national and industry standards [1] Group 2: Technological Innovation - The successful development of the CRTSIII type high-speed rail track slab has broken the foreign technology monopoly and serves as a crucial support for China's "going out" strategy for high-speed rail [1]

证券代码：603969 证券简称：银龙股份 公告编号：2025-067 天津银龙预应力材料股份有限公司 关于取消2025年第二次临时股东会的公告 公司于 2025 年 9 月 19 日召开五届董事会第十六次会议，审议通过《关于召 开公司 2025 年第二次临时股东会的议案》，拟将名称由"天津银龙预应力材料股 份有限公司"变更为"银龙集团股份有限公司"。因市场监督管理局未审批通过 该名称，公司决定取消原定于 2025 年 11 月 25 日召开的 2025 年第二次临时股东 会，后续将根据实际情况择期召开董事会审议相关事项，股东会召开通知将另行 公告。 因本次股东会取消，为保障所有股东的合法投票权益，如有与本次股东会有 关的投票统计不计入公司投票表决统计。 三、 所涉及议案的后续处理 本次取消临时股东会事项符合《公司法》《上市公司股东会规则》和《上海 证券交易所股票上市规则》等法律法规及《公司章程》等相关规定。公司将积极 推进相关工作进展，根据实际情况择期召开董事会审议相关事项，并决定股东会 会议时间安排。 1. 取消的股东会的类型和届次 2025年第二次临时股东会 2. 取消股东会的召开日期：2025 年 1 ...

证券代码：603969 证券简称：银龙股份 公告编号：2025-066 公司于 2025 年 9 月 19 日召开五届董事会第十六次会议，审议通过《关于召 开公司 2025 年第二次临时股东会的议案》，拟将名称由"天津银龙预应力材料 股份有限公司"变更为"银龙集团股份有限公司"。因市场监督管理局未审批通 过该名称，公司决定取消原定于 2025 年 11 月 25 日召开的 2025 年第二次临时股 东会，后续将根据实际情况择期召开董事会审议相关事项，股东会召开通知将另 行公告。 表决结果：9 票赞成，0 票反对，0 票弃权。 具体内容详见公司同日刊登于上海证券交易所网站（www.sse.com.cn）及《上 海证券报》《中国证券报》的《天津银龙预应力材料股份有限公司关于取消 2025 年第二次临时股东会的公告》（公告编号：2025-067）。 特此公告。 天津银龙预应力材料股份有限公司 第五届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 天津银龙预应力材料股份有限公司 ...

Core Viewpoint - Silver Dragon Co., Ltd. has shown a significant increase in stock price and financial performance, indicating potential growth opportunities in the pre-stressed concrete materials sector [2][3]. Financial Performance - As of September 30, 2025, Silver Dragon achieved a revenue of 2.443 billion yuan, representing a year-on-year growth of 10.93% - The net profit attributable to shareholders reached 273 million yuan, marking a substantial increase of 61.89% year-on-year [2]. Stock Performance - The stock price of Silver Dragon has increased by 44.76% year-to-date, with a recent 2.00% rise in the last trading session [2]. - Over the past 20 days, the stock has decreased by 6.93%, while it has increased by 6.38% over the last 60 days [2]. Shareholder Information - As of September 30, 2025, the number of shareholders is 27,300, a decrease of 7.63% from the previous period - The average number of circulating shares per shareholder is 30,892, which has increased by 8.26% [2]. Dividends - Since its A-share listing, Silver Dragon has distributed a total of 612 million yuan in dividends, with 179 million yuan distributed over the past three years [3]. Institutional Holdings - Notable new institutional shareholders include Guangfa Value Core Mixed Fund, holding 25.9019 million shares, and Guangfa Small Cap Growth Mixed Fund, holding 9.7747 million shares [3].

Group 1 - The company, Tianjin Yinlong Prestressed Materials Co., Ltd., has established a private equity investment fund in collaboration with Beijing Honghui International Energy Technology Development Co., Ltd. and Botong (Tianjin) Venture Capital Co., Ltd. to invest in the new energy and energy storage sectors [2] - The fund aims to identify high-growth potential projects with innovative technologies that align with industry development trends [2] - The fund has completed the necessary registration procedures with the Asset Management Association of China and has obtained the Private Investment Fund Registration Certificate [2] Group 2 - The fund is named Tianjin Zhongyuan Botong New Energy Venture Capital Fund Partnership (Limited Partnership) [2] - The fund manager is Botong (Tianjin) Venture Capital Co., Ltd., and the custodian is Bohai Bank Co., Ltd. [2] - The registration was completed on November 11, 2025, with the registration code SBJN32 [2]

证券日报网讯 11月13日晚间，银龙股份发布公告称，公司与北京泓慧国际能源技术发展股份有限公 司、博通（天津）创业投资有限公司共同投资设立产业基金并签订合伙协议，合伙企业主要投资于新能 源产业、储能领域相关项目，致力于挖掘具有高增长潜力、符合产业发展趋势的优质项目。近日，公司 收到基金管理人通知，该基金已根据相关法律法规的要求，在中国证券投资基金业协会完成私募投资基 金备案手续，并取得《私募投资基金备案证明》。 （文章来源：证券日报） ...

Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]

为满足天津银龙预应力材料股份有限公司（以下简称"银龙股份"或"公司"） 战略发展需求及产业联动效应，进一步深化合作，公司与北京泓慧国际能源技术 发展股份有限公司、博通（天津）创业投资有限公司共同投资设立产业基金并签 订合伙协议，合伙企业主要投资于新能源产业、储能领域相关项目，致力于挖掘 具有创新性技术、高增长潜力、符合产业发展趋势的优质项目。具体内容详见公 司于 2025 年 8 月 1 日披露于《中国证券报》《上海证券报》及上海证券交易所网 站（www.sse.com.cn）的《天津银龙预应力材料股份有限公司关于参与投资私募 股权投资基金的公告》（公告编号：2025-038）。 二、进展情况 近日，公司收到基金管理人通知，该基金已根据《证券投资基金法》和《私 募投资基金监督管理暂行办法》等法律法规的要求，在中国证券投资基金业协会 完成私募投资基金备案手续，并取得《私募投资基金备案证明》。具体备案信息 如下： 基金名称：天津众源博通新能创业投资基金合伙企业（有限合伙） 证券代码：603969 证券简称：银龙股份 公告编号：2025-065 天津银龙预应力材料股份有限公司 关于参与设立的私募股权投资基金备案完成 ...

Group 1 - The company has announced the completion of private investment fund registration procedures in collaboration with Beijing Honghui International Energy Technology Development Co., Ltd. and Botong (Tianjin) Venture Capital Co., Ltd. [1] - The newly established industrial fund will primarily invest in projects related to the new energy industry and energy storage sector [1]